Rocket Lab (NASDAQ:RKLB) Stock Price Down 7.4% – Here’s What Happened

Rocket Lab Corporation (NASDAQ:RKLB) traded down 7.4% on Friday. The stock traded as low as $53.19 and last traded at $54.73. Approximately 16,426,892 shares were traded during mid-day trading, a decline of 28% from the average daily volume of 22,760,232 shares. The stock had previously closed at $59.10.

Trending Headlines about Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Analyst Upgrades and Downgrades

Several brokerages have commented on RKLB. Piper Sandler began coverage on Rocket Lab in a report on Wednesday, July 15th. They issued a “neutral” rating and a $83.00 price objective on the stock. Citizens Jmp dropped their price target on shares of Rocket Lab from $130.00 to $90.00 and set a “market outperform” rating for the company in a research note on Friday, October 16th. Wall Street Zen downgraded Rocket Lab from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Berenberg Bank started coverage on Rocket Lab in a research report on Wednesday, September 2nd. They set a “buy” rating and a $83.00 price objective for the company. Finally, Citigroup reissued a “market outperform” rating on shares of Rocket Lab in a research report on Friday, October 16th. Three analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $102.05.

Rocket Lab Stock Down 7.4%

The firm has a 50-day simple moving average of $64.59 and a 200 day simple moving average of $80.10. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.48 and a quick ratio of 4.98. The company has a market capitalization of $32.75 billion, a PE ratio of -202.70 and a beta of 2.93.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings results on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. The business had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. On average, research analysts predict that Rocket Lab Corporation will post -0.20 EPS for the current fiscal year.

Insider Buying and Selling at Rocket Lab

In related news, CAO Agostino Ricupati sold 669 shares of Rocket Lab stock in a transaction on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $46,582.47. Following the completion of the sale, the chief accounting officer owned 26,863 shares of the company’s stock, valued at approximately $1,870,470.69. The trade was a 2.43% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Arjun Kampani sold 6,034 shares of the business’s stock in a transaction dated Thursday, August 27th. The stock was sold at an average price of $66.65, for a total value of $402,166.10. Following the transaction, the senior vice president directly owned 250,917 shares of the company’s stock, valued at $16,723,618.05. This represents a 2.35% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 400,749 shares of company stock worth $26,964,474 over the last quarter. Insiders own 8.40% of the company’s stock.

Hedge Funds Weigh In On Rocket Lab

Several hedge funds have recently added to or reduced their stakes in RKLB. Versant Capital Management Inc boosted its position in shares of Rocket Lab by 5.1% during the second quarter. Versant Capital Management Inc now owns 2,049 shares of the rocket manufacturer’s stock worth $208,000 after purchasing an additional 100 shares in the last quarter. Bartlett & CO. Wealth Management LLC grew its position in shares of Rocket Lab by 7.1% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 1,869 shares of the rocket manufacturer’s stock worth $120,000 after purchasing an additional 124 shares in the last quarter. Parvin Asset Management LLC increased its holdings in Rocket Lab by 4.0% in the 1st quarter. Parvin Asset Management LLC now owns 3,665 shares of the rocket manufacturer’s stock valued at $235,000 after buying an additional 140 shares during the period. Wedmont Private Capital raised its holdings in shares of Rocket Lab by 3.5% during the 3rd quarter. Wedmont Private Capital now owns 4,644 shares of the rocket manufacturer’s stock worth $318,000 after buying an additional 157 shares in the last quarter. Finally, DMC Group LLC increased its position in Rocket Lab by 5.0% during the 2nd quarter. DMC Group LLC now owns 3,553 shares of the rocket manufacturer’s stock worth $361,000 after purchasing an additional 170 shares in the last quarter. Institutional investors own 71.78% of the company’s stock.

Rocket Lab Company Profile

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.